Tin tức & Cập nhật

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021 bởi

Tenofovir alafenamide (TAF), administered during the second or third trimester of pregnancy, may prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV) infection, according to two studies presented as posters at ILC 2021.

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021

Adding amoxicillin/clavulanate to prednisolone yields no survival benefit in severe alcoholic hepatitis

06 Aug 2021 bởi

The addition of amoxicillin/clavulanate to prednisolone does not extend survival among patients with severe alcoholic hepatitis, though it may reduce infection risk, according to a French study presented at ILC 2021.

Adding amoxicillin/clavulanate to prednisolone yields no survival benefit in severe alcoholic hepatitis

06 Aug 2021

Thiopurines do not exacerbate risk of post-ERC pancreatitis

05 Aug 2021

In patients with primary sclerosing cholangitis, past or present use of thiopurines does not increase the risk of post-endoscopic retrograde cholangiography (ERC) pancreatitis, a recent study has found.

Thiopurines do not exacerbate risk of post-ERC pancreatitis

05 Aug 2021

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

02 Aug 2021

New drug applications approved by US FDA as of 16-31 July 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

02 Aug 2021

TVB-2640 impresses in nonalcoholic steatohepatitis

01 Aug 2021

Use of the fatty acid synthase (FASN) inhibitor TVB-2640 in the treatment of patients with nonalcoholic steatohepatitis (NASH) yields dose-dependent improvements in liver fat as well as biochemical, inflammatory, and fibrotic biomarkers, according to the results of the phase IIa trial 3V2640-CLIN-005 (FASCINATE-1).

TVB-2640 impresses in nonalcoholic steatohepatitis

01 Aug 2021

What factors affect time to recovery in patients with drug-induced liver injury?

31 Jul 2021

Serum bilirubin and alkaline phosphatase levels, along with the extent of drug metabolism, all affect the time to recover from drug-induced liver injury (DILI), a recent study has found.

What factors affect time to recovery in patients with drug-induced liver injury?

31 Jul 2021

Muscle fat content linked to nonalcoholic steatohepatitis

29 Jul 2021

Muscle fat content shares a strong correlation with nonalcoholic steatohepatitis in patients with obesity, a recent study has found. Muscle mass, on the other hand, has no such effect.

Muscle fat content linked to nonalcoholic steatohepatitis

29 Jul 2021

Pioglitazone confers benefits for fatty liver in patients with type 2 diabetes

29 Jul 2021

Treatment with pioglitazone, even at low doses, helps improve indices of nonalcoholic fatty liver disease (NAFLD) such as liver steatosis, inflammation, and systemic and adipose tissue insulin resistance in patients with type 2 diabetes, according to a study.

Pioglitazone confers benefits for fatty liver in patients with type 2 diabetes

29 Jul 2021

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

24 Jul 2021

Treatment for chronic hepatitis B virus (CHB) infection results in significant reductions in risk of cirrhosis among noncirrhotic CHB patients, according to a study.

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

24 Jul 2021

Cirrhosis due to NASH tied to worse outcomes relative to HBV

23 Jul 2021

Prognosis is much poorer in patients with decompensated cirrhosis due to nonalcoholic steatohepatitis (NASH) than in those with hepatitis B virus (HBV), with the former experiencing more complications and utilizing more healthcare resources, reveals a study.

Cirrhosis due to NASH tied to worse outcomes relative to HBV

23 Jul 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Adding amoxicillin/clavulanate to prednisolone yields no survival benefit in severe alcoholic hepatitis

Adding amoxicillin/clavulanate to prednisolone yields no survival benefit in severe alcoholic hepatitis

Thiopurines do not exacerbate risk of post-ERC pancreatitis

Thiopurines do not exacerbate risk of post-ERC pancreatitis

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

Original New Drug Application Approvals by US FDA (16 - 31 July 2021)

TVB-2640 impresses in nonalcoholic steatohepatitis

TVB-2640 impresses in nonalcoholic steatohepatitis

What factors affect time to recovery in patients with drug-induced liver injury?

What factors affect time to recovery in patients with drug-induced liver injury?

Muscle fat content linked to nonalcoholic steatohepatitis

Muscle fat content linked to nonalcoholic steatohepatitis

Pioglitazone confers benefits for fatty liver in patients with type 2 diabetes

Pioglitazone confers benefits for fatty liver in patients with type 2 diabetes

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Cirrhosis due to NASH tied to worse outcomes relative to HBV

Cirrhosis due to NASH tied to worse outcomes relative to HBV